Who owns IKENA ONCOLOGY INC?
- Ticker: IKNA
- CUSIP Number: 45175g108
Tip: Access positions for across all investors
Analyze quarterly positions in Ikena Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ikena Oncology stock
Who bought or sold IKENA ONCOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors | 5.0M | $6.4M | 0% | Mar 2025 |
|
| Blue Owl Capital Holdings | 4.1M | $6.7M | 0% | Dec 2024 |
|
| BVF | 4.0M | $5.1M | 0% | Mar 2025 |
|
| BML Capital Management | 3.7M | $4.7M | 3% | Mar 2025 |
|
| OrbiMed Advisors | 3.5M | $4.5M | 0% | Mar 2025 |
|
| Deep Track Capital | 2.5M | $3.2M | 100% | Mar 2025 |
|
| Omega Fund Management | 2.2M | $3.7M | 0% | Dec 2024 |
|
| Vanguard Group | 1.4M | $1.8M | 0% | Mar 2025 |
|
| Gilead Sciences | 1.2M | $1.5M | -42% | Mar 2025 |
|
| Adage Capital Partners GP | 800k | $1.0M | 0% | Mar 2025 |
|
| NEA Management Company | 600k | $768k | 0% | Mar 2025 |
|
| Sofinnova Ventures | 383k | $628k | 0% | Dec 2024 |
|
| BlackRock | 349k | $446k | -1% | Mar 2025 |
|
| Geode Capital Management | 317k | $406k | -3% | Mar 2025 |
|
| Peapod Lane Capital | 296k | $379k | -42% | Mar 2025 |
|
| Renaissance Technologies | 295k | $377k | -11% | Mar 2025 |
|
| Aldebaran Capital | 248k | $317k | 100% | Mar 2025 |
|
| Jacobs Levy Equity Management | 246k | $314k | -25% | Mar 2025 |
|
| Acadian Asset Management | 210k | $266k | -27% | Mar 2025 |
|
| Bridgeway Capital Management | 153k | $196k | 0% | Mar 2025 |
|
| Two Sigma Advisers | 151k | $194k | -4% | Mar 2025 |
|
| UBS Group | 101k | $129k | 40% | Mar 2025 |
|
| State Street Corporation | 92k | $118k | 0% | Mar 2025 |
|
| Deuterium Capital Management | 81k | $103k | 0% | Mar 2025 |
|
| Citadel Advisors | 80k | $102k | -1% | Mar 2025 |
|
| Two Sigma Investments | 79k | $102k | -21% | Mar 2025 |
|
| Goldman Sachs Group | 77k | $98k | 62% | Mar 2025 |
|
| BBR Partners | 70k | $90k | 0% | Mar 2025 |
|
| Millennium Management | 70k | $89k | -65% | Mar 2025 |
|
| Barclays | 66k | $85k | -66% | Mar 2025 |
|
| Northern Trust | 58k | $74k | 0% | Mar 2025 |
|
| XTX Topco | 57k | $72k | 351% | Mar 2025 |
|
| Squarepoint Ops | 44k | $72k | 100% | Dec 2024 |
|
| Dimensional Fund Advisors | 39k | $63k | 0% | Dec 2024 |
|
| Vazirani Asset Management | 25k | $41k | -78% | Dec 2024 |
|
| Berkshire Asset Management | 20k | $22k | 0% | Mar 2025 |
|
| Engineers Gate Manager | 19k | $31k | 100% | Dec 2024 |
|
| Prudential Financial | 18k | $30k | -39% | Dec 2024 |
|
| JustInvest | 16k | $27k | -8% | Dec 2024 |
|
| Morgan Stanley | 15k | $23k | 100% | Dec 2024 |
|
| FMR | 5.1k | $6.5k | -52% | Mar 2025 |
|
| Tower Research Capital | 3.6k | $6.0k | 94% | Dec 2024 |
|
| Jpmorgan Chase & Co | 849.00 | $1.1k | -99% | Mar 2025 |
|
| Coldstream Capital Management | 525.00 | $672.000000 | 100% | Mar 2025 |
|
| Bnp Paribas Arbitrage, Snc | 315.00 | $403.011000 | -99% | Mar 2025 |
|
| Bank of America Corporation | 251.00 | $411.991400 | 26% | Dec 2024 |
|
| SRS Capital Advisors | 235.00 | $386.011000 | -21% | Dec 2024 |
|
| Farther Finance Advisors | 108.00 | $135.000000 | 0% | Mar 2025 |
|
| NISA Investment Advisors | 69.00 | $88.002600 | -30% | Mar 2025 |
|
| SBI Securities | 3.00 | $3.999900 | 0% | Mar 2025 |
|
Who sold out of Ikena Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Marquette Asset Management | Dec 2024 | 73k | $120k |
| JBF Capital | Dec 2024 | 73k | $119k |
| Susquehanna International | Sep 2024 | 57k | $99k |
| Point72 Asia | Dec 2024 | 21k | $35k |
| Qube Research & Technologies | Sep 2024 | 17k | $30k |
| Charles Schwab Investment Management | Dec 2024 | 12k | $20k |
| Russell Investments | Sep 2024 | 2.7k | $4.7k |
| Advisor Group Holdings | Dec 2024 | 1.5k | $2.5k |
| Point72 | Dec 2024 | 564.00 | $925.975200 |